Animal and human research studies have shown that CBD can help decrease feelings of isolation, relieve symptoms of autism, and reduce the effects of post-traumatic stress disorder (PTSD). It seems that CBD can calm the brain and support the hippocampus, which is an important area of the brain for healthy emotions and memory. Low levels of serotonin may play a role in the development of depression, and animal studies suggest that CBD could have an impact on these receptors, which could produce antidepressant effects. In recent years, several researchers have investigated the use of CBD to support good mental health.
People may choose to take a full-spectrum product because research has shown that when cannabinoids, including THC and CBD, are taken together, the therapeutic impact is magnified, a phenomenon known as the entourage effect. However, these benefits of CBD alone and in combination with THC should be explored in face-to-face studies. Given its potential antidepressant benefits, the role of CBD in unipolar and bipolar depression should be explored. One more study found that CBD oil significantly reduced seizure activity in children with Dravet syndrome, a complex childhood epileptic disorder, compared to placebo (2).
Over the course of a week, CBD significantly reduced signal-induced cravings of heroin users, withdrawal anxiety, resting heart rate, and saliva cortisol levels. To summarize clinical results, study designs, and limitations for the use of CBD and nabiximols (whole plant extract of Cannabis sativa L.) Like full-spectrum CBD, products labeled as broad-spectrum contain multiple cannabinoids, which supposedly provide the therapeutic benefits of the environmental effect without the psychoactive effects of THC. A number of other studies have found that CBD may be effective for people with social anxiety and other anxiety-related disorders (1). The results showed a significant reduction in severe and acute pain and cold and itchy sensations in those who used topical CBD compared to those who used placebo.
And according to preclinical evidence from rodent studies, CBD may have beneficial effects on arthritis-related pain and inflammation, but human studies are lacking (. This article provides a comprehensive review of the evidence supporting the use of CBD and CBD-containing compounds, such as nabiximols, to treat psychiatric disorders. In view of the (albeit limited) evidence of treatment-resistant schizophrenia, the role of CBD in the early stages of psychosis or as an adjunct medication should be explored. Researchers are currently investigating how CBD can be used in the treatment of other mental health disorders.
